BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2018
View Archived Issues
Discovery and characterization of novel spirocyclic sigma receptor ligands
Read More
miR-335 delivery by extracellular vesicles restores tumor suppressor activity in breast cancer model
Read More
Phase II data for ruxolitinib in PTCL and CTCL enriched for JAK/STAT pathway alterations
Read More
Lilly initiates phase I study of LY-3454738 for atopic dermatitis
Read More
Anergis completes proof-of-concept study of second-generation COP allergy vaccines
Read More
XEN-901 shows promise in preclinical and first-in-human studies
Read More
Synthetic astaxanthin derivative shows promise in the treatment of amyotrophic lateral sclerosis
Read More
Takeda presents first-in-human data for TAK-653
Read More
Eli Lilly presents phase II data from nextMONARCH 1 study
Read More
Novel class of antibacterial compounds targeting the LPS transport system of Gram-negative bacteria
Read More
CRISPR activation uses scissors as squeezers
Read More
Axovant licenses gene therapies for GM1 and GM2 gangliosidosis from University of Massachusetts
Read More
Vaximm initiates phase I/II study of VXM-01 plus avelumab for the treatment of glioblastoma
Read More
Taiho Pharmaceutical divulges KDM1A inhibitors
Read More
Gut bacteria eat, make neurotransmitter
Read More
Oxford University Innovation presents bacterial beta-lactamase inhibitors
Read More
Pfizer initiates phase III program for its 20-valent pneumococcal conjugate vaccine
Read More
Suzhou Autopharm Biopharmaceutical synthesizes MAP1LC3B inhibitors
Read More
Topadur Pharma discloses PDE5A inhibitors
Read More
FDA approves Nplate for pediatric patients with immune thrombocytopenia
Read More
Trastuzumab biosimilar Herzuma approved by FDA
Read More
Janssen Pharmaceuticals and collaborator identify new antivirals for dengue
Read More
Vedanta initiates phase II study of VE-303 for recurrent C. difficile infection
Read More
FDA clears IND application for BBT-877 for IPF
Read More
Valneva begins phase II with VLA-15 for Lyme disease
Read More
DSMB recommends continuation of phase III RESOLVE-IT study of elafibranor in NASH
Read More
C4X Discovery and Horizon Discovery establish target discovery partnership
Read More
FDA approves Motegrity for adults with chronic idiopathic constipation
Read More
Concert initiates phase I program with CTP-692 for adjunctive treatment of schizophrenia
Read More